Connor, Clark & Lunn Investment Management (CC&L)’s Haemonetics HAE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13M | Sell |
174,287
-50,085
| -22% | -$3.74M | 0.05% | 336 |
|
|
2025
Q1 | $14.3M | Sell |
224,372
-27,770
| -11% | -$1.76M | 0.06% | 249 |
|
|
2024
Q4 | $19.7M | Buy |
252,142
+31,689
| +14% | +$2.47M | 0.09% | 174 |
|
|
2024
Q3 | $17.7M | Buy |
220,453
+179,621
| +440% | +$14.4M | 0.09% | 184 |
|
|
2024
Q2 | $3.38M | Buy |
+40,832
| New | +$3.38M | 0.01% | 522 |
|
|
2023
Q3 | – | Sell |
-17,963
| Closed | -$1.53M | – | 1426 |
|
|
2023
Q2 | $1.53M | Buy |
+17,963
| New | +$1.53M | 0.01% | 675 |
|
|
2018
Q3 | – | Sell |
-3,800
| Closed | -$341K | – | 1012 |
|
|
2018
Q2 | $341K | Buy |
+3,800
| New | +$341K | ﹤0.01% | 855 |
|
|
2017
Q4 | – | Sell |
-5,925
| Closed | -$266K | – | 808 |
|
|
2017
Q3 | $266K | Buy |
5,925
+700
| +13% | +$31.4K | ﹤0.01% | 719 |
|
|
2017
Q2 | $206K | Buy |
+5,225
| New | +$206K | ﹤0.01% | 741 |
|
|
2016
Q3 | – | Sell |
-10,000
| Closed | -$290K | – | 868 |
|
|
2016
Q2 | $290K | Sell |
10,000
-1,325
| -12% | -$38.4K | ﹤0.01% | 679 |
|
|
2016
Q1 | $396K | Sell |
11,325
-2,900
| -20% | -$101K | ﹤0.01% | 604 |
|
|
2015
Q4 | $459K | Sell |
14,225
-13,575
| -49% | -$438K | ﹤0.01% | 558 |
|
|
2015
Q3 | $898K | Buy |
+27,800
| New | +$898K | 0.01% | 422 |
|